BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 16919891)

  • 1. Attention-deficit hyperactivity disorder may be associated with decreased central brain-derived neurotrophic factor activity: clinical and therapeutic implications.
    Tsai SJ
    Med Hypotheses; 2007; 68(4):896-9. PubMed ID: 16919891
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased central brain-derived neurotrophic factor activity could be a risk factor for substance abuse: Implications for treatment.
    Tsai SJ
    Med Hypotheses; 2007; 68(2):410-4. PubMed ID: 16824691
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Signal transducer and activator of transcription 6 (STAT6) and attention-deficit hyperactivity disorder: a speculative hypothesis.
    Tsai SJ
    Med Hypotheses; 2006; 67(6):1342-4. PubMed ID: 16844317
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased levels of plasma brain-derived neurotrophic factor (BDNF) in children with attention deficit-hyperactivity disorder (ADHD).
    Shim SH; Hwangbo Y; Kwon YJ; Jeong HY; Lee BH; Lee HJ; Kim YK
    Prog Neuropsychopharmacol Biol Psychiatry; 2008 Dec; 32(8):1824-8. PubMed ID: 18760321
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Semax, an analogue of adrenocorticotropin (4-10), is a potential agent for the treatment of attention-deficit hyperactivity disorder and Rett syndrome.
    Tsai SJ
    Med Hypotheses; 2007; 68(5):1144-6. PubMed ID: 16996699
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Does excessive daytime sleepiness contribute to explaining the association between obesity and ADHD symptoms?
    Cortese S; Konofal E; Dalla Bernardina B; Mouren MC; Lecendreux M
    Med Hypotheses; 2008; 70(1):12-6. PubMed ID: 17587509
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The P11, tPA/plasminogen system and brain-derived neurotrophic factor: Implications for the pathogenesis of major depression and the therapeutic mechanism of antidepressants.
    Tsai SJ
    Med Hypotheses; 2007; 68(1):180-3. PubMed ID: 16890384
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A study of how socioeconomic status moderates the relationship between SNPs encompassing BDNF and ADHD symptom counts in ADHD families.
    Lasky-Su J; Faraone SV; Lange C; Tsuang MT; Doyle AE; Smoller JW; Laird NM; Biederman J
    Behav Genet; 2007 May; 37(3):487-97. PubMed ID: 17216343
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Animal models concerning the role of dopamine in attention-deficit hyperactivity disorder.
    van der Kooij MA; Glennon JC
    Neurosci Biobehav Rev; 2007; 31(4):597-618. PubMed ID: 17316796
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [ADHD and attachment processes: are they related?].
    Franc N; Maury M; Purper-Ouakil D
    Encephale; 2009 Jun; 35(3):256-61. PubMed ID: 19540412
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association study of 10 genes encoding neurotrophic factors and their receptors in adult and child attention-deficit/hyperactivity disorder.
    Ribasés M; Hervás A; Ramos-Quiroga JA; Bosch R; Bielsa A; Gastaminza X; Fernández-Anguiano M; Nogueira M; Gómez-Barros N; Valero S; Gratacòs M; Estivill X; Casas M; Cormand B; Bayés M
    Biol Psychiatry; 2008 May; 63(10):935-45. PubMed ID: 18179783
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Is autism caused by early hyperactivity of brain-derived neurotrophic factor?
    Tsai SJ
    Med Hypotheses; 2005; 65(1):79-82. PubMed ID: 15893122
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interacting effects of the dopamine transporter gene and psychosocial adversity on attention-deficit/hyperactivity disorder symptoms among 15-year-olds from a high-risk community sample.
    Laucht M; Skowronek MH; Becker K; Schmidt MH; Esser G; Schulze TG; Rietschel M
    Arch Gen Psychiatry; 2007 May; 64(5):585-90. PubMed ID: 17485610
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Towards further understanding of the co-morbidity between attention deficit hyperactivity disorder and bipolar disorder: a MRI study of brain volumes.
    Biederman J; Makris N; Valera EM; Monuteaux MC; Goldstein JM; Buka S; Boriel DL; Bandyopadhyay S; Kennedy DN; Caviness VS; Bush G; Aleardi M; Hammerness P; Faraone SV; Seidman LJ
    Psychol Med; 2008 Jul; 38(7):1045-56. PubMed ID: 17935640
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The heterogeneity of causes and courses of attention-deficit/hyperactivity disorder.
    Steinhausen HC
    Acta Psychiatr Scand; 2009 Nov; 120(5):392-9. PubMed ID: 19807721
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Collicular dysfunction in attention deficit hyperactivity disorder.
    Overton PG
    Med Hypotheses; 2008; 70(6):1121-7. PubMed ID: 18215471
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Down-regulation of the Trk-B signal pathway: the possible pathogenesis of major depression.
    Tsai SJ
    Med Hypotheses; 2004; 62(2):215-8. PubMed ID: 14962629
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A functional serotonin transporter promoter gene polymorphism increases ADHD symptoms in delinquents: interaction with adverse childhood environment.
    Retz W; Freitag CM; Retz-Junginger P; Wenzler D; Schneider M; Kissling C; Thome J; Rösler M
    Psychiatry Res; 2008 Mar; 158(2):123-31. PubMed ID: 18155777
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Strengths and limitations of genetic models of ADHD.
    Gainetdinov RR
    Atten Defic Hyperact Disord; 2010 Mar; 2(1):21-30. PubMed ID: 21432587
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Statins may enhance the proteolytic cleavage of proBDNF: implications for the treatment of depression.
    Tsai SJ
    Med Hypotheses; 2007; 68(6):1296-9. PubMed ID: 17097821
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.